270 related articles for article (PubMed ID: 30151977)
1. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.
Payne J; Aban I; Hilliard LM; Madison J; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD
Pediatr Blood Cancer; 2018 Dec; 65(12):e27420. PubMed ID: 30151977
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
[TBL] [Abstract][Full Text] [Related]
4. The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain.
Muslu CS; Kopetsky M; Nimmer M; Visotcky A; Fraser R; Brousseau DC
Pediatr Blood Cancer; 2020 Sep; 67(9):e28268. PubMed ID: 32614150
[TBL] [Abstract][Full Text] [Related]
5. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
[TBL] [Abstract][Full Text] [Related]
6. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ
Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
[TBL] [Abstract][Full Text] [Related]
7. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
[TBL] [Abstract][Full Text] [Related]
8. A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department.
Schefft MR; Swaffar C; Newlin J; Noda C; Sisler I
Pediatr Blood Cancer; 2018 Oct; 65(10):e27274. PubMed ID: 29856534
[TBL] [Abstract][Full Text] [Related]
9. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
10. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
Myrick R; Blakemore S; Waite E; Pernell B; Madan-Swain A; Hilliard L; Lebensburger J
Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
[TBL] [Abstract][Full Text] [Related]
11. Impact of individualized pain plan on the emergency management of children with sickle cell disease.
Krishnamurti L; Smith-Packard B; Gupta A; Campbell M; Gunawardena S; Saladino R
Pediatr Blood Cancer; 2014 Oct; 61(10):1747-53. PubMed ID: 24962217
[TBL] [Abstract][Full Text] [Related]
12. Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease.
Puri L; Morgan KJ; Anghelescu DL
Curr Opin Support Palliat Care; 2019 Dec; 13(4):402-407. PubMed ID: 31157658
[TBL] [Abstract][Full Text] [Related]
13. Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency Department.
Lin SM; Strouse JJ; Whiteman LN; Anders J; Stewart RW
Pediatr Emerg Care; 2016 Jan; 32(1):14-6. PubMed ID: 25834959
[TBL] [Abstract][Full Text] [Related]
14. Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.
Telfer P; Bahal N; Lo A; Challands J
Br J Haematol; 2014 Jul; 166(2):157-64. PubMed ID: 24750050
[TBL] [Abstract][Full Text] [Related]
15. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell transfusion therapy for sickle cell patients with frequent painful events.
Hilliard LM; Kulkarni V; Sen B; Caldwell C; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD
Pediatr Blood Cancer; 2018 Dec; 65(12):e27423. PubMed ID: 30152184
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Use of Individualized Pain Plans in Sickle Cell Patients Presenting to the Emergency Department.
Della-Moretta S; Delatore L; Purcell M; Huang Y; Heinlein M; Adkins E; Desai P
Ann Emerg Med; 2020 Sep; 76(3S):S21-S27. PubMed ID: 32928458
[TBL] [Abstract][Full Text] [Related]
18. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
[TBL] [Abstract][Full Text] [Related]
19. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
Mathias MD; McCavit TL
Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
[TBL] [Abstract][Full Text] [Related]
20. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
